Invention Grant
- Patent Title: Human TNFRSF25 antibody
-
Application No.: US15964770Application Date: 2018-04-27
-
Publication No.: US10683358B2Publication Date: 2020-06-16
- Inventor: Taylor H. Schreiber
- Applicant: Pelican Therapeutics, Inc.
- Applicant Address: US NC Durham
- Assignee: Pelican Therapeutics, Inc.
- Current Assignee: Pelican Therapeutics, Inc.
- Current Assignee Address: US NC Durham
- Agency: Morgan, Lewis & Bockius LLP
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; A61K39/00
Abstract:
Antibodies and antigen binding fragments that bind specifically to TNFRSF25 are provided herein. Methods for using the antibodies and antigen binding fragments to, for example, stimulate proliferation of human T cells (e.g., CD8+ T cells) and to treat cancer patients also are provided.
Public/Granted literature
- US20180312598A1 HUMAN TNFRSF25 ANTIBODY Public/Granted day:2018-11-01
Information query
